Powerful Medical Inc. software

PMcardio is an advanced artificial intelligence platform designed to interpret 12-lead ECGs rapidly and accurately. It caters to both individual practitioners and healthcare organizations by providing instant, AI-powered interpretations. The technology focuses on diagnosing over 40 ECG conditions, including acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF), with high precision. The platform uses sophisticated algorithms and explainability heatmaps to help clinicians visualize which ECG features influenced the diagnosis. Supported by clinical validation in over 15 independent studies, PMcardio is trusted by over 100,000 healthcare professionals globally. It enhances decision-making at first patient contact, improving patient outcomes by ensuring quicker referrals and reducing false activations of catheterization labs. Furthermore, the product adheres to stringent regulatory standards including CE Marking under EU MDR, GDPR compliance, and ISO certifications, ensuring data security and patient safety. The integration capabilities allow for seamless deployment across hospital networks, supporting the standardization and efficiency of cardiac care services.

PMcardio is an advanced platform that utilizes AI for ECG interpretation, aimed at transforming cardiovascular diagnostics and care. Designed for both individual and organizational use, PMcardio offers precise AI-driven interpretations of ECG data to aid in the timely diagnosis of various cardiac conditions. Key functionalities include the detection of acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction, enhancing the decision-making process at critical first patient contact points. As a CE-marked class IIb medical device, it adheres to EU MDR standards. It seamlessly integrates with existing hospital workflows and systems, supporting formats like JSON, HL7, DICOM, SCP, PDF, and XML. Furthermore, PMcardio complies with HIPAA and GDPR for data security, facilitating safe patient data processing. Its clinical capabilities have been validated in over 30 studies, demonstrating significant accuracy and efficiency improvements in cardiac care coordination and diagnosis, ultimately aiming to reduce unnecessary medical procedures and optimize healthcare resources.

PMcardio is an AI-powered platform designed to enhance cardiovascular diagnostics through cutting-edge ECG interpretation. It provides rapid and accurate analyses of heart conditions using advanced algorithms that identify issues such as reduced left ventricular ejection fraction, acute ST-elevation myocardial infarction (STEMI), and STEMI-equivalent patterns. PMcardio's technology facilitates earlier diagnosis and immediate referrals to specialists, optimizing patient care. Compatible with any 12-lead ECG, the platform streamlines cardiac assessments and reduces time for clinical decisions. Its widespread implementation across hospitals showcases its role in advancing cardiac care, aiding in cost reduction by minimizing the need for hospitalizations and complex interventions. Although CE-marked for use in Europe and the UK, it awaits FDA clearance for the US market. The tool stands out for its ability to democratize advanced cardiac diagnostic capabilities, ensuring broader accessibility and application in healthcare settings.

The PMcardio platform by Powerful Medical leverages advanced AI technology to deliver fast and accurate ECG interpretations across various healthcare settings. This platform supports clinicians with AI-driven insights, providing immediate analysis and early detection of critical conditions such as ST-elevation myocardial infarction (STEMI) and left ventricular ejection fraction (LVEF) reductions. The system facilitates enhanced decision-making, integrating seamlessly with electronic health records (EHR) to optimize clinical workflows. Trained on a robust global dataset of over 2.5 million ECGs, PMcardio is backed by extensive clinical validation in more than 15 studies, involving over 10,000 patients. It offers explainability through heatmaps that highlight ECG features influencing the diagnosis, reducing false-positive cath lab activations by more than 90%. As a Class IIb medical device, it is EU MDR CE-marked, GDPR, and HIPAA compliant, ensuring high standards of data security and regulatory adherence.